Assessment of Copd Management Compliance With Gold 2024 Requirements in Poltava Region

Abstract

The aim of the study was to determine the compliance of chronic obstructive pulmonary disease (COPD) diagnosis and treatment with GOLD 2024 guidelines by assessing the quality of life of patients. Materials and methods. 23 control subjects, 23 patients with COPD II, 11 patients with COPD III, group E took part in the observational study. All subjects underwent an assessment of external respiratory function using spirometry, an assessment of exercise tolerance – 6 MWD, quality of life was assessed using SF-36 and SGRQ questionnaires, severity of dyspnoea and severity of symptoms – mMRC and САТ-test, and the treatment received at the time of inclusion in the study was analysed. Results. The conformity of diagnosis and verification of COPD diagnosis was confirmed by spirometry data, deviation of physical activity tolerance was demonstrated by the 6MWD test. Patients have a low level of physical activity, which provokes mental health problems, according to the SGRQ and SF-36 questionnaires. According to the results of the mMRC and CAT test, patients experienced symptoms of shortness of breath even with light physical activity, were forced to stop walking or slow down, which negatively affected their ability to work. Patients did not receive pharmacological treatment in accordance with GOLD 2024 and were likely to have unstable symptom control. Conclusion. Due to inadequate medical treatment before GOLD 2024, a significant decrease in external respiratory parameters and quality of life, as well as symptom severity, was detected.